These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 30176511)

  • 21. Polyester-based nanoparticles for nucleic acid delivery.
    Zhao J; Weng G; Li J; Zhu J; Zhao J
    Mater Sci Eng C Mater Biol Appl; 2018 Nov; 92():983-994. PubMed ID: 30184828
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tumor-targeted and multi-stimuli responsive drug delivery system for near-infrared light induced chemo-phototherapy and photoacoustic tomography.
    Feng Q; Zhang Y; Zhang W; Shan X; Yuan Y; Zhang H; Hou L; Zhang Z
    Acta Biomater; 2016 Jul; 38():129-42. PubMed ID: 27090593
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Targeted Alpha Therapy and Nanocarrier Approach.
    Silindir-Gunay M; Karpuz M; Ozer AY
    Cancer Biother Radiopharm; 2020 Aug; 35(6):446-458. PubMed ID: 32302510
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Targeted nanomedicine for cancer therapeutics: Towards precision medicine overcoming drug resistance.
    Bar-Zeev M; Livney YD; Assaraf YG
    Drug Resist Updat; 2017 Mar; 31():15-30. PubMed ID: 28867241
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anticancer use of nanoparticles as nucleic acid carriers.
    Gozuacik D; Yagci-Acar HF; Akkoc Y; Kosar A; Dogan-Ekici AI; Ekici S
    J Biomed Nanotechnol; 2014 Sep; 10(9):1751-83. PubMed ID: 25992440
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Advances in Molecular Modeling of Nanoparticle-Nucleic Acid Interfaces.
    Nash JA; Kwansa AL; Peerless JS; Kim HS; Yingling YG
    Bioconjug Chem; 2017 Jan; 28(1):3-10. PubMed ID: 27776214
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Targeted nanoparticles for colorectal cancer.
    Cisterna BA; Kamaly N; Choi WI; Tavakkoli A; Farokhzad OC; Vilos C
    Nanomedicine (Lond); 2016 Sep; 11(18):2443-56. PubMed ID: 27529192
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Polymeric nanoparticles for targeted drug delivery system for cancer therapy.
    Masood F
    Mater Sci Eng C Mater Biol Appl; 2016 Mar; 60():569-578. PubMed ID: 26706565
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Membrane-core nanoparticles for cancer nanomedicine.
    Guo J; Huang L
    Adv Drug Deliv Rev; 2020; 156():23-39. PubMed ID: 32450105
    [TBL] [Abstract][Full Text] [Related]  

  • 30. PLGA nanoparticles containing various anticancer agents and tumour delivery by EPR effect.
    Acharya S; Sahoo SK
    Adv Drug Deliv Rev; 2011 Mar; 63(3):170-83. PubMed ID: 20965219
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Peptides for nucleic acid delivery.
    Lehto T; Ezzat K; Wood MJA; El Andaloussi S
    Adv Drug Deliv Rev; 2016 Nov; 106(Pt A):172-182. PubMed ID: 27349594
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Injectable Drug-Loaded Nanocarriers for Lung Cancer Treatments.
    Yu HP; Aljuffali IA; Fang JY
    Curr Pharm Des; 2017; 23(3):481-494. PubMed ID: 28292243
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nanoparticles-mediated drug delivery approaches for cancer targeting: a review.
    Sultana S; Khan MR; Kumar M; Kumar S; Ali M
    J Drug Target; 2013 Feb; 21(2):107-25. PubMed ID: 22873288
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Induction of Cytokines by Nucleic Acid Nanoparticles (NANPs) Depends on the Type of Delivery Carrier.
    Avila YI; Chandler M; Cedrone E; Newton HS; Richardson M; Xu J; Clogston JD; Liptrott NJ; Afonin KA; Dobrovolskaia MA
    Molecules; 2021 Jan; 26(3):. PubMed ID: 33513786
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A small molecule nanodrug consisting of amphiphilic targeting ligand-chemotherapy drug conjugate for targeted cancer therapy.
    Mou Q; Ma Y; Zhu X; Yan D
    J Control Release; 2016 May; 230():34-44. PubMed ID: 27040815
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nanomedicine: An effective tool in cancer therapy.
    Aftab S; Shah A; Nadhman A; Kurbanoglu S; Aysıl Ozkan S; Dionysiou DD; Shukla SS; Aminabhavi TM
    Int J Pharm; 2018 Apr; 540(1-2):132-149. PubMed ID: 29427746
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Polymer decorated gold nanoparticles in nanomedicine conjugates.
    Capek I
    Adv Colloid Interface Sci; 2017 Nov; 249():386-399. PubMed ID: 28259207
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Non-viral Delivery Systems for Breast Cancer Gene Therapy.
    Vaseghi G; Rafiee L; Javanmard SH
    Curr Gene Ther; 2017; 17(2):147-153. PubMed ID: 28595562
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nucleic acid nanomedicines in Phase II/III clinical trials: translation of nucleic acid therapies for reprogramming cells.
    Herrera VL; Colby AH; Ruiz-Opazo N; Coleman DG; Grinstaff MW
    Nanomedicine (Lond); 2018 Aug; 13(16):2083-2098. PubMed ID: 30204054
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Smart IR780 Theranostic Nanocarrier for Tumor-Specific Therapy: Hyperthermia-Mediated Bubble-Generating and Folate-Targeted Liposomes.
    Guo F; Yu M; Wang J; Tan F; Li N
    ACS Appl Mater Interfaces; 2015 Sep; 7(37):20556-67. PubMed ID: 26322900
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.